My lab uses state-of-the-art molecular imaging technologies to monitor disease progression and to evaluate therapeutic efficacy. On the whole, my lab is split between three seemingly divergent subjects, namely the imaging of bacterial infections, assessing tumor development processes during cancer and tracking neutrophil response during inflammation.
My lab also has an ongoing interest in developing non-invasive imaging agents to measure the increased inflammatory burden experienced by mice in models of cancer, atherosclerosis and rheumatoid arthritis.
Current research is at the crossroads of molecular imaging, biochemistry and infectious disease research.
